Apixaban linearity profile for hydrotropic solubilization

by Santosh Karajgi, Shripad Potadar
Published 2020-01-01

Anticoagulantes orales directos: monitorización y reversión, dos grandes dificultades

by Irene González Aguirre
Published 2017-06-01

Bariatric Surgery can Lower the Efficacy of DOACs

by Zouheir Ibrahim Bitar, Ossama Sajeh Maadarani, Mohamed Jaber Mohsen, Nawal Usamah Alkazemi
Published 2020-09-01

Sangrado hepático espontaneo en paciente tratado con Apixaban

by Ignacio Ramil Freán, Maria Vares Gonzalez, Joaquín Serrano Arreba
Published 2019-10-01

Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban

by Anis TR, Jandreau W
Published 2021-09-01

Large de novo ascending aortic thrombus successfully treated with anticoagulation

by Mustafa Houmsse, Asia McDavid, Ahmet Kilic
Published 2018-06-01

New oral anticoagulants and cardiac safety: do we have a problem?

by E. M. Nifontov
Published 2018-04-01

Prevention of venous thromboembolism with rivaroxaban and apixaban in orthopedic surgery

by Antonijević Nebojša, Kanjuh Vladimir, Živković Ivana, Jovanović Ljubica, Vukčević Miodrag, Apostolović Milan
Published 2020-01-01

Apixaban

by Gianluca Airoldi, Mauro Campanini
Published 2013-03-01

A prospective multicenter study of direct comparison of feasibility and safety of pulmonary vein isolation using the minimally interrupted apixaban between second‐generation cryoba...

by Atsuhiko Yagishita, Masahiko Goya, Yoshito Iesaka, Junichi Nitta, Atsushi Takahashi, Yasutoshi Nagata, Hitoshi Hachiya, Osamu Inaba, Yukihiro Inamura, Yasuaki Tanaka, Keita Watanabe, Susumu Tao, Yasuhiro Shirai, Tasuku Yamamoto, Shinya Shiohira, Kikou Akiyoshi, Masahiro Sekigawa, Shingo Maeda, Takeshi Sasaki, Yoshihide Takahashi, Mihoko Kawabata, Kenzo Hirao, for the J‐HIT investigators
Published 2020-08-01

Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation

by Jayasree Pillarisetti, Madhu Reddy, Mamatha Vodapally, Tulasi Annapureddy, Maruthsakhi Molugu, Donita Atkins, Sudharani Bommana, Rhea Pimentel, Raghuveer Dendi, Dhanunjaya Lakkireddy
Published 2020-11-01

Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial

by Vinai C. Bhagirath, John W. Eikelboom, Jack Hirsh, Michiel Coppens, Jeffrey Ginsberg, Thomas Vanassche, Fei Yuan, Noel Chan, Salim Yusuf, Stuart J. Connolly
Published 2017-07-01

Successful resolution with apixaban of a massive left atrial appendage thrombus due to nonrheumatic atrial fibrillation: A case report and review

by Bader Abu Ghalyoun, Matthew Lempel, Hamid Shaaban, Fayez Shamoon
Published 2018-01-01

The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants

by Jamshed Dalal, Abhay Bhave, Abraham Oomman, Amit Vora, Anil Saxena, Dhiman Kahali, Fali Poncha, D.S. Gambhir, Jaydip Ray Chaudhuri, Nakul Sinha, Saumitra Ray, S.S. Iyengar, Suvro Banerjee, Upendra Kaul
Published 2015-12-01

Non-valvular atrial fibrillation: impact of apixaban on patient outcomes

by Ioannou A, Tsappa I, Metaxa S, Missouris CG
Published 2017-11-01

Oral and parenteral anticoagulants: New kids on the block

by S Aditya
Published 2012-01-01

Quick reference guide to apixaban

by Hurst KV, O'Callaghan JM, Handa A
Published 2017-07-01

Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology

by S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova
Published 2019-05-01

Rectus sheath hematoma associated with apixaban

by Kulothungan Gunasekaran, Amanda R. McFee Winans, Swetha Murthi, Mudassar Raees Ahmad, Scott Kaatz
Published 2017-08-01

Preparation, Characterization and Ex vivo Permeability Study of Transdermal Apixaban O/W Nanoemulsion Based Gel

by Mustafa R. Abdulbaqi, Nawal A.Rajab
Published 2020-12-01